Trevi Therapeutics, Inc. TRVI Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -30.2%+22.4pp | -52.6%-22.0pp | -30.6%+16.2pp | -46.8%+106pp | |
| Return on invested capital | -42.6%+44.6pp | -87.2%-40.9pp | -46.3%— | —— | |
| Liquidity | |||||
| Current ratio | 19.7×+9.2× | 10.4×-4.6× | 15×+5.9× | 9.2×+6.2× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $1.36+39.2% | $0.98+17.2% | $0.83-49.9% | $1.66+123% | |
| Valuation | |||||
| Market capitalization | $1.61B+336% | $368.19M+176% | $133.31M-29.6% | $189.4M+686% | |
| Price / book | 8.8×+5.1× | 3.7×+2.1× | 1.6×-0.1× | 1.8×+0.4× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Trevi Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Trevi Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.